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Abstract
Background: Technological support using e-health mobile applications (m-health) is a promising strategy to improve
the adherence to healthy lifestyles in breast cancer survivors (excess in energy intake or low physical activity are
determinants of the risk of recurrence, second cancers and cancer mortality). Moreover, cancer rehabilitation
programs supervised by health professionals are needed due to the inherent characteristics of these breast cancer
patients. Our main objective is to compare the clinical efficacy of a m-health lifestyle intervention system alone versus
an integral strategy to improve Quality of Life in breast cancer survivors.
Methods: This therapeutic superiority study will use a two-arm, assessor blinded parallel RCT design. Women will be
eligible if: they are diagnosed of stage I, II or III-A breast cancer; are between 25 and 75 years old; have a Body Mass
Index > 25 kg/m2; they have basic ability to use mobile apps; they had completed adjuvant therapy except for
hormone therapy; and they have some functional shoulder limitations. Participants will be randomized to one of
the following groups: integral group will use a mobile application (BENECA APP) and will receive a face-to-face
rehabilitation (8-weeks); m-health group will use the BENECA app for 2-months and will received usual care
information. Study endpoints will be assessed after 8 weeks and 6 months. The primary outcome will be Quality
of Life measured by The European Organization for Research and Treatment of Cancer Quality of Life Questionnaire Core
and breast module. The secondary outcomes: body composition; upper-body functionality (handgrip, Disability of the
Arm, Shoulder and Hand questionnaire, goniometry); cognitive function (Wechsler Adult Intelligence Scale, Trail Making
Test); anxiety and depression (Hospital Anxiety and Depression Scale); physical fitness (Short version of the Minnesota
Leisure Time Physical Activity Questionnaire, Self-Efficacy Scale for Physical Activity); accelerometry and lymphedema.
Discussion: This study has been designed to seek to address the new needs for support and treatment of breast cancer
survivors, reflecting the emerging need to merge new low cost treatment options with much-needed involvement of
health professionals in this type of patients.
Trial registration: ClinicalTrials.gov Identifier: NCT02817724 (date of registration: 22/06/2016).
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Background
Cancer is one of the most incident diseases worldwide.
Over 14 million new cancer cases occur every year, but
are projected to reach approximately 22 million by 2030
[1]. Among all cancer types, breast cancer is the most
commonly diagnosed cancer in women, and approxi-
mately 4.4 million women worldwide live with a diagno-
sis of breast cancer [2]. Fortunately, the survival rate is
very encouraging; the estimated number of deaths from
breast cancer is estimated to be less than one-third of
new cases [1]. Developments in screening and improved
treatments for breast cancer have led to improved sur-
vival, and it is beginning to be regarded as a chronic
disease [3, 4]. This new perspective of the disease has
led to a growing need for long-term treatments [4] with
an integrative strategy that takes into account the pa-
tients’ lifestyles and physical, cognitive and emotional
impairments [5–7].
Regarding the importance of the patients’ lifestyles
(in physical activity and diet), the literature highlights
the importance of maintaining healthy lifestyles to re-
duce the risk of recurrence, secondary cancers or death.
There is strong evidence about the efficacy and safety
of exercise and healthy diet to improve the patients’
quality of life (QoL) [8, 9] and reduce the effects of
cancer [10, 11]. Recent research reveals that even when
patients know the benefits of interventions aimed at pro-
moting energy balance among cancer survivors (in terms
of intake and physical activity), it is unrealistic to expect
that most of them, who have a strong sedentary habit, will
comply with the current good practice guidelines [10, 12].
In addition, survivors report difficulties in adhering to
and maintaining an appropriate lifestyle [12]. Conse-
quently, this energy imbalance increases the risk of
cancer recurrence [13] and, along with the functional
limitations and emotional/occupational imbalance, re-
duces the QoL of breast cancer survivors (BCS) [14].
New strategies with a comprehensive approach of sup-
port must be developed to improve the adherence and
motivation of these patients and to reduce the high cost
involved in creating individualized exercise programs
and diets [15]. Currently, technological support is a
promising strategy that could improve issues, such as
barriers of distance, time, cost and motivational aspects
[16]. Telehealth systems, which are based on computers
and mobile applications (m-health), offer a promising
approach for both dietary and physical activity assess-
ments [17] and the patients’ motivation can be signifi-
cantly increased through the immediate feedback provided
by these systems [18]. A recent study has developed a
mobile application to simultaneously collect data on
diet and physical activity in adults [17], but, to our
knowledge, no programs exist that simultaneously col-
lect data on diet and physical activity in cancer patients
and provide immediate feedback with individualized
recommendations.
In addition to the need to improve these patients’ life-
styles, the patients may experience physical, cognitive
and emotional impairments. The most common upper
body symptoms reported by BCS are related to shoul-
der impairments [19–21], although much research has
supported the practice of performing early exercises to
avoid limitations of range of motion (ROM) in the
shoulder [22, 23]. Moreover, cognitive impairment oc-
curs in 10%–50% of these women [24, 25], and the
emotional distress caused by shifts in social support
and the fear of recurrence and death has also impacted
women’s wellbeing [26, 27]. The performance of daily
tasks (such as activities in daily living, work, and leisure
tasks) are influence by all these complications and,
along with unhealthy lifestyle habits, affect the overall
QoL [22].
In this sense, occupational therapy is an effective inter-
vention to improve the patients’ QoL, ROM or distress
in different conditions [28–30]. However, to our know-
ledge, the only published randomized controlled trial
evaluating occupational therapy in BCS is an interven-
tion aimed at reducing the limitations of rural patients
in their daily activities [31]. The authors found that a
telephone-based problem-solving occupational therapy
intervention program was feasible and had positive
effects on the patients’ function, QoL and emotional
state. However, the study had methodological limita-
tions, such as a small simple size and intervention bias.
Other previous studies with the aim of evaluating the
effects of occupational therapy on cancer patients had
several limitations, such as including any type of cancer
[32–36], the use of a non-randomized controlled trial
(RCT) approach [33–35, 37, 38], and pilot studies [31, 36]
involving very few patients [31, 33, 36–38].
This study arises from the need to establish an integra-
tive and multidisciplinary strategy to support BCS by
taking advantage of the features of these two proposals:
first, the functionality and independence provided by a
mobile application that patients can use when and wher-
ever they choose; secondly, the imperative need for a su-
pervised face-to-face intervention by a health professional,
due to the inherent characteristics of these patients. Our
study aims to compare the clinical efficacy of an m-health
lifestyle intervention system alone versus an integrative
strategy that also includes a face-to-face intervention in
BCS. In this manuscript, we describe the design and
methods of the study.
Methods
Objectives
The main objective of this RCT is to assess if an inte-
grated strategy that uses an m-health system in addition
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to a face-to-face treatment is better than the use of the
m-health system alone to improve the immediate and
long-term QoL of BCS. Second, we want to examine the
effects of the interventions on the overall impact on
functionality, body composition, anxiety and depression,
physical measurement, lymphedema and cognitive func-
tion. The integral group will use the m-health and re-
ceive three occupational therapy sessions each week for
an 8-week period. We will also study the effect of a 24-
week period without rehabilitation on the studied vari-
ables. We hypothesize that support care based on an
Occupational Therapy-supervised rehabilitation program
will promote functionality and the combination with the
mobile system will improve the patients’ lifestyles and
QoL, reduce distress, and improve cognitive function and
arm mobility.
Research design and methods
The present study is a parallel group, assessor-blind, su-
periority RCT that will be conducted using assessments at
baseline and immediately after the 8-weeks intervention.
Follow-up measurements will be collected for 24 weeks
after the end of the 8-week intervention period, resulting
in a total trial data collection period of 32 weeks. We will
use two separate assessment days to avoid fatigue in pa-
tients. In Table 1 is shown the study assessment schedule.
Participants
A total of 80 eligible (see inclusion criteria below) BCS
will be randomized into the integral group (N = 40) or
the m-health group (N = 40). For feasibility, the study is
conducted in three waves. During the first year of the
study (from January to December 2016), we will prepare
protocols, establish the measurement techniques, and
enrol the first 25 women in the study. At the beginning
of the second year of the study (between January and
April 2017), we will enrol an additional 30 women, and
in the third stage, we will enrol the remaining 25
women. In summary, the target sample size of 80 BCS
will be achieved in these 3 waves.
The integral group will receive the m-health plus an
8-week occupational therapy onsite program, and the
m-health group will only use the app. Participants will be
enrolled in this study by oncologists from the Hospital
Virgen de las Nieves (Breast Unit) and the Hospital Clínico
San Cecilio, Granada (Spain). The Research Ethics
Committee of the province of Granada approved this
study.
Eligibility criteria
Eligible women require: 1) to be between 25.0 and
74.9 years-old, 2) to be diagnosed of stage I, II or IIIA
breast cancer, 3) to have medical clearance of
participation, 4) to be overweight or obese, according
to the Spanish Society for the Study of Obesity (SEEDO)
[39], 5) to have basic ability to use mobile apps or living
with someone who has this ability, 6) completion of ad-
juvant therapy except for hormone therapy, 7) to have
some functional or ROM limitations measures by
goniometry and the Disabilities of the Arm, Shoulder
and Hand (DASH) questionnaire, and 8) to have
signed informed consent and have interest in improving
lifestyle.
The exclusion criteria were defined as follows: history
of cancer recurrence, to have had chronic disease or
orthopaedic issues that would interfere with ability to
participate in this rehabilitation program, or to have had
uncontrolled hypertension (diastolic pressure > 95 mm Hg).
Outcome measures
The primary outcome measure is QoL. The secondary
outcome variables include body composition, active
range of motion (AROM), functionality, anxiety and
depression, and cognitive function. Other variables of
interest include muscular strength and free-living
physical activity.



















EORTC QLQ-C30 x x x
EORT QLQ-BR23 x x x
Day 2 testing
WAIS-IVa(subtest) x x x
Trail Making Test (TMT) x x x
Handgrip strength x x x




DASH x x x
Goniometry x x x
aWorking memory and processing speed subtest
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Primary outcome measure
Quality of life: The European Organization for Research
and Treatment of Cancer Quality of Life Questionnaire
Core 30 (EORTC QLQ-C30) version 3.0 [40]: We will
use the EORT QLQ-C30 to assess QoL. This question-
naire is one of the most widely used instruments to
measure QoL in cancer patients. The QLQ-C30 is com-
posed of both multi-item scales and single-item mea-
sures, as well as five functional scales, three symptom
scales, a global health status/QoL scale, and six single
items. The scores must be averaged and linearly trans-
formed to obtain a range of scores from 0 to 100, with a
higher score representing a greater response level. Thus,
a high score for a functional scale represents a healthy
level of functioning and a high score for the global
health status represents a high QoL, but a high score for
the symptom scale represents a high level of symptom-
atology [41]. The test/retest reliability is high for all scales,
ranging from 0.82 to 0.91 [40].
The European Organization for Research and Treatment
of Cancer Breast Cancer-Specific Quality of Life Question-
naire (EORT QLQ-BR23) [42]: This questionnaire is a
breast cancer module of the EORTC QLQ-C30 that con-
tains 23 items rated on a four-point scale ranging from 1
(not at all) to 4 (very much). The items assess the side
effects of therapy, arm symptoms, breast symptoms, body
image, and sexual function. Additionally, there are single
items assessing sexual enjoyment, anxiety caused by hair
loss, and future outlook. The scores range between 0–100
points. The procedure for scoring the breast cancer mod-
ule is the same as the EORTC QLQ-C30 [41]. For scales
evaluating function, a higher score represents a higher
level of functioning. For scales evaluating symptoms, a
higher score indicates more severe symptoms. The reli-
ability has been shown to be high to moderate (Cronbach’s
α ranged between 0.46 – 0.94) [42].
Other outcome measures
Body composition
Height and weight will be measured. Body mass index,
fat mass, lean body mass, abdominal adipose tissue and
bone mineral density will also be assessed by conducting
Dual-energy X-ray absorptiometry (DXA, Discovery
densitometer from HOLOGIC, QDR 4500 W) using
protocols reported in previous studies [43, 44]. This as-
sessment tool has previously been used in breast cancer
patients [45, 46].
Muscular strength
The handgrip strength test will be assessed using a
digital dynamometer (TKK 5101 Grip-D; Takey, Tokyo,
Japan). Following the protocol described by Ruiz-Ruiz
et al. [47], the optimal grip span will be determined by a
simple algorithm to adapt the dynamometer. Throughout
the whole test, BCS will be in a bipedal position; they have
to put their arm in complete extension without touching
any part of their body [18], repeating the test three times
with each hand, alternately. There will be a delay of one
minute between each test. The mean of the three tests will
be used for the main analysis. This measurement has been
demonstrated to be valid and reliable [48].
Upper body functionality
The disability of the arm, shoulder and hand (DASH)
questionnaire: the American Academy of Orthopedic
Surgeons introduced the DASH questionnaire as a specific
instrument to measure upper extremity functionality [49].
It is one of the most extensively used tools [50]. Of the
30-items that are included in the DASH questionnaire: 21
items ask about the degree of difficulty in physical ac-
tivities; 5 items ask about the severity of some pain
symptoms; and the final 4 items ask about other activi-
ties such as social activities, sleep, work or self-image.
The impact of the symptoms on each activity is also
assessed. The scale score ranges from 0 to 100 points;
the higher the score, the greater the disability [51].
The reliability of the Spanish version has a Cronbach’s
α = 0.96 [52].
Active range of motion (AROM)
Shoulder AROM measurements will be obtained using a
standard, two-armed goniometer, which is described as
the clinical gold standard [53]. The patients will be asked
to actively move their arms as much as they can to
obtain measurements (in degrees) of flexion, extension,
abduction, internal rotation and external rotation of the
shoulder [23]. The movement will be validated by the
interviewer and motion compensation will be limited to
avoid overestimating the scores.
Cognitive function
Wechsler Adult Intelligence Scale (WAIS-IV): The
WAIS-IV is an intelligence test designed to measure
cognitive ability in adults and older adolescents and
provides the most advanced adult measure of cognitive
ability [54]. WAIS-IV subtests will be administered and
scored according to standardized procedures [55]. For
feasibility issues and because specific subtests provide
information on a specific cognitive function (and can
be used separately [55]), we will use two of the four
index scores that compose the test: the Working Memory
Index (WMI) and the Processing Speed Index (PSI). The
WMI includes two subtests, Arithmetic and Digit Span,
and the PSI also includes two subtests, Digit Symbol-
Coding and Symbol Search.
The Trail Making Test (TMT) measures the flexibility
of thinking using a visual-motor sequencing task and is
one of the most important neuropsychological tests,
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providing information on speed of processing, visual
search, mental flexibility, scanning and executive func-
tions [56]. It is formed by two subtests. TMT-A requires
the participant to draw lines that sequentially connect
several encircled numbers (1 to 25) distributed on a
sheet of paper. TMT-B is similar in requirements, but in
this case, the participant must alternate between numbers
and letters (e.g., 1, A, 2, B, 3, C, etc.). The score is based
on the amount of time required to complete the task.
Anxiety and depression
The Hospital Anxiety and Depression Scale (HADS):
This scale consists of 14 items with two subscales (seven
items for anxiety and seven for depression) and a score
which ranges from 0 to 21 for each subscale. The ques-
tionnaire contemplates a cutoff point of 11 or above to
consider anxiety and depression conditions [57, 58].
Physical fitness
Short Version of the Minnesota Leisure Time Physical
Activity Questionnaire (VREM) [59]: This questionnaire
is a short version of the original Minnesota question-
naire [60] and is composed of 5 items. It asks for the
period in a typical week that the participants perform
routine housework activities (cleaning house and go
shopping on foot). In addition, it asks about activities
performed during the last month or in a typical month
for the other items, such as walking, working in the
garden, playing sports or dancing and climbing stairs.
Finally, energy expenditure is calculated (in METS-min/
14 days) and the participant is classified from sedentary
to very active according to their energy expenditure [59].
Self-Efficacy Scale for Physical Activity (EAF): The EAF
is a validated instrument that determines the participants’
beliefs about their own abilities to perform physical activi-
ties (self-efficacy for physical activity). It also allows us to
identify the barriers and limitations that prevent the user
from practicing this behaviour and the strength they
require to perform regular physical activity. The EAF con-
sists of three domains: scheduled physical exercise, physi-
cal activity in daily activities and walking. A total of 39
items are rated from 0 to 10; the higher the score, the
greater the ability to perform the activity [61, 62].
Accelerometry
Accelerometry will be used to obtain data about physical
activity and sedentary time for each participant, fol-
lowing a previously published protocol for usage and
analysis [63]. A pre-programmed tri-axial accelerometer
(ActiGraph GT3X+, Pensacola, Fl., US) and a daily ques-
tionnaire will be given to BCS. The participants will wear
the accelerometer for 8 consecutive days. They will be
instructed to wear the accelerometer on their lower back
for the whole day (including when sleeping) but to take it
off during aquatic activities. They will also receive an in-
formation sheet with detailed instructions. Participants
will be included in the main analysis if the device records
data for at least 4 days over a period of at least 10 h each
day. Data will be collected at intervals of 1 min. Nonwear
periods (intervals of 60 consecutive minutes with zero
counts) and the first day of wearing the device will be ex-
cluded from analyses. Accelerometer data will be down-
loaded to the same computer used to initialize them [18].
Lymphedema
We will measure changes in size or volume of the upper
limbs to diagnose lymphedema. An inextensible flexible
tape 0.5 cm wide x 2 m long with an accuracy of 0.1 cm
will be used following the protocol using in some previ-
ous studies [18, 64], which has been shown to be valid
and reliable [65, 66].
Sample size
The sample size and power calculations for this trial
were obtained through overall Health-Related QoL
(HRQoL) using EORTC QLQ-C30 version 3.0 [40], and
taking into account previously reported data [67] a mini-
mally important difference from 5 to 10 points was con-
sidered. Assuming that integral group increase HRQoL
in BCS in compared with m-health group [18] we can
detect differences of at least 5% with a power of 90%
and an α of 0.05 with two groups (Integral group and
m-health group) of 36 participants assuming similar
standard deviation (approximately 7 points). A maxi-
mum loss at follow-up of 10% will be allowed to face a
possible drop-out rate [9]. Hence, we will recruit 80 BCS
(40 in each group). Fig. 1 shows the flow diagram of the
study participants.
Randomization and blinding
To reduce the risk of bias during the assessment, after
completion of the baseline assessment we will allocate
eligible patients randomly either m-health or integral
groups into three randomization waves, using computer-
generated numbers (EPIDAT 3.1, Xunta de Galicia). An
external member will introduce the sequence in sealed
opaque envelopes. Assessment staff will be blinded to
patients’ randomization assignment and the staff respon-
sible of the rehabilitation program will not be able to
change any assignment. After the 6-month follow-up
period, and because of ethical implications, once the last
outcome variable has been measured we will invite par-
ticipants of the m-health group to participate into the
face-to-face rehabilitation program.
Integral group
The intervention will be implemented by the CUIDATE
research group. The supervised face-to-face program
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involves two parts (8 weeks in total). The participants
will may use the BENECA System (mobile app) daily,
which aims to recover a healthy lifestyle in BCS (in
terms of energy balance: physical activity and dietary).
On the second day of the assessment, staff will install
the app on the participants’ mobile phones and will train
them to use it. Furthermore, the women will receive
telephone calls and text messages (as required) to re-
solve any questions and provide suggestions, and a video
tutorial on how to use the application is also available
on the web.
Moreover, participant will receive a supervised face-
to-face rehabilitation program. This intervention con-
sists of a supervised-occupational therapy rehabilitation
program at the iMUDS centre (Mixed Institute University
Sport and Health). Because there is no information
about the ideal occupational therapy program for
breast cancer patients, we have developed a compre-
hensive program that covers most of the physical,
cognitive and emotional needs of these patients after
oncology treatment from the occupational therapy
perspective.
The second part is based on the fact that this span has
been used in previous RCTs that have similar outcomes
and samples [9, 18]. The occupational therapy program
includes 3 weekly sessions of 60 to 90 min each. The
weekly sessions will be distributed as follows: 2 sessions/
week in a ROM-cognitive subprogram (approximately
50 min/session) using therapeutic workshops and individ-
ualized treatment that focus on improving the ROM,
muscle strength and endurance, and manipulative skill
and energy conservation as well as cognitive activities; 3
sessions/week of a psychomotricity program (approxi-
mately 45 min/session) including activities to improve
functional capacity and address fatigue and pain as well
as a warm-up period and relaxation techniques; and fi-
nally, 1 session/week of a psychosocial intervention
(approximately 30 min/session), working on areas of
ergonomics, techniques of energy conservation and fa-
tigue management, job anxiety, coping techniques and
occupational balance. All of these exercises will be
assigned to women in the integral group according to
their perceived needs at the baseline assessment. These
needs will be established based on the fatigue levels,
pain, functional capacity, ROM, and distress levels
reported by the patients. Therefore, each participant
will receive individual and progressive training (for
example, the number and type of exercises, series,
repetitions and so on). Efforts will be made to prevent the
integral group from receiving additional physical care.
Fig. 1 Flow diagram showing the recruitment of patients
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M-HEALT: BENECA APP system
BENECA asks users to register their food and drinks
and the different activities performed during the previous
day. With an open structure and four time periods, the
application will take the form of a questionnaire on the
diet (over the last 24 h) and a record of daily activities in
terms of duration and intensity. Users also record their
weight (kg) and height (cm). After entering the informa-
tion, the system will provide the patient information about
their energy balance and general recommendations on
physical activity according to their individual profile, using
the reference guide for exercise in cancer patients from
the American College of Sports Medicine [68]. Addition-
ally, it provides recommended substitutions for foods that
are considered potentially carcinogenic with others that
may have a protective capacity against cancer, according
to the guidelines of the American Cancer Society [11, 69]
and the recommendations of the WCRF about the
consumption of food of plant and animal origins, food
with low energy density, etc. Furthermore, the program
also detects the presence of an energy imbalance.
Telephone calls
The CUIDATE group will make the telephone calls and
send messages of encouragement. On the one hand, with
this calls, participants will be able to solve any problems
with the usage of BENECA app. Moreover, we will check
the patients’ improvement and satisfaction. On the other
hand, the aim of messages will be to stimulate not only
the adherence with BENECA app but also with the
program.
M-Health group
Because it is a study of therapeutic superiority, the m-
health group will use the BENECA app for 2 months
and will receive some general recommendations about
healthy lifestyle, stress management and occupational
balance in paper format. After completion of this study,
the m-health participants will be given the opportunity
to participate in the supervised face-to-face program due
to the ethical concerns of the CUIDATE group. The data
obtained will be not used in this study.
Data analysis
All analyses will be carried out using STATA/SE 14.0
StataCorp, College Station, TX, USA) or using Statistical
Program for Social Sciences (IBM© SPSS© Statistic
version 20, Corp., Armonk, NY). We will check the nor-
mal distribution of variables with Kolmogorov-Smirnov
and Shapiro-Wilk test, as appropriate, and the differences
at baseline between groups with Chi-square test or
Student t-test, as appropriate. The main analysis will be
repeated measures analyses of the covariance (ANCOVA)
with age, type of surgery, tumour stage and time since
diagnosis as covariates. Intergroup effect sizes will be
calculated to provide change magnitude information. We
will use the intention-to-treat principle for all analyses.
Discussion
This RCT will investigate whether there are clinically
relevant differences in improvements in the QoL of BCS
between an integral strategy and the use of the m-health
system alone. This study has been designed to address
the new needs for support and treatment of breast
cancer survivors, reflecting the emerging need to merge
new, low cost treatment options with the much-needed
involvement of health professionals in the treatment of
this type of patients. The supervised program includes
not only strengthening and range of motion exercises of
the shoulder, which are necessary in these patients [9],
but also features a cognitive [25] and psychosocial [27]
approach in a single intervention program which,
together with the use of the m-health application [17],
provides the integral character of the project.
In addition, most studies in cancer patients have been
conducted with a rehabilitation team comprising nurses,
psychologists and physiotherapists [8, 27]. For this rea-
son, we chose to use a supervised face-to-face rehabilita-
tion program conducted by an occupational therapist,
due to the holistic and integrative approach of the
discipline. Although we expect to see improvements in
the primary outcome in both groups, we hypothesize
that the combination of the supervised program and the
m-health system will cause significant differences in
QoL compared with the m-health group. QoL improve-
ment is considered an indicator of cancer rehabilitation
success [70]. If this integral option is effective, it will
highlight the need for health systems to include disci-
plines such as occupational therapy in the supportive
care of cancer patients during the survival period, as well
as the potential advantage and cost reduction provided
using a mobile app. Moreover, the results of this study
could garner support for the use of this type of strategy
in an increasing number of 17.8 million cancer patients
in the European Union [71], with a high proportion of
them claiming adequate rehabilitation services.
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